Major Cost Savings On Top Cancer Drugs With India-Approved Alternatives
Top 5 Affordable India-Made Cancer Medications Available at SaveRxCanada
Palbociclib (Brand: Ibrance)
India Generic: Palnat – $4.38 per capsule
Patients prescribed Palbociclib can expect to pay over $200 per capsule in the U.S. The Indian version, Palnat, offers approximately 98% savings.
Ibrutinib (Brand: Imbruvica)
India Generic: Ibrunat – $6.95 per capsule
With U.S. prices soaring over $480 per capsule, Ibrunat provides patients with nearly 99% in savings, making ongoing treatment significantly more accessible.
Enzalutamide (Brand: Xtandi)
India Generic: Xylutide – $5.23 per tablet
Compared to the U.S. price of $115 or more per tablet, Xylutide offers up to 95% cost reduction, easing the financial burden on prostate cancer patients.
Osimertinib (Brand: Tagrisso)
India Generic: Tagrix – $416.67 per tablet
While still a premium medication, Tagrix is approximately 42% cheaper than its U.S. counterpart, which averages around $720 per tablet.
Abemaciclib (Brand: Verzenio)
India Generic: Ramiven – $36.67 per tablet
Ramiven delivers a dramatic 88% savings compared to the U.S. price of over $300 per tablet, offering new hope for breast cancer patients.
Note: U.S. brand-name prices are based on publicly available retail pharmacy data as of Q1 2025. Individual pricing may vary.
Free Shipping
These generic cancer medications are available through the RxSelect program, which includes free shipping on all orders.
A Valid Prescription Is Required
All medications ordered through SaveRxCanada require a valid prescription from a licensed healthcare provider. This ensures patient safety and compliance with medical and legal
SaveRxCanada works only with licensed international pharmacies that meet strict dispensing regulations.
Why It Matters
Even with insurance, many cancer patients face crippling out-of-pocket costs. With these India-approved generics, patients now have a safe, effective, and legal pathway to affordable care.
About SaveRxCanada
SaveRxCanada is a leading online pharmacy referral service that connects patients with licensed international pharmacies, primarily in India. The platform offers deep discounts on medications for chronic conditions such as cancer, diabetes, arthritis, and more. With a focus on affordability, security, and patient care, SaveRxCanada helps bridge the global gap in medication access.
To learn more or to place a secure order, visit: SaveRxCanada
This press release was issued through 24-7PressRelease. For further information, visit .
SOURCE SaveRxCanada

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.
Most popular stories
Market Research

- Origin Summit Unveils Second Wave Of Global Icons Ahead Of Debut During KBW
- Dupoin Reports Global Growth, Regulatory Coverage, And User Experience Insights
- Jpmorgan Product Head Joins GSR Trading MD To Build Institutional Staking Markets
- Betfury Is At SBC Summit Lisbon 2025: Affiliate Growth In Focus
- Hola Prime Expands Its Platform Ecosystem With Next-Gen Tradelocker
- Zebu Live 2025 Welcomes Coinbase, Solana, And Other Leaders Together For UK's Biggest Web3 Summit
Comments
No comment